Strides Arcolab

Bangalore-based drug firm Strides Arcolab today said its subsidiary Onco Therapies received the US drug regulator's nod to sell cancer medicine Methotrexate Injection in the American market.
Onco Therapies Ltd,

Drug firm Strides Arcolab today said its consolidated profit surged to Rs 68. 41 crore for the fourth quarter ended December 31 on forex gains and robust sales across

Bangalore-based Strides Arcolab has sold 94 per cent shareholding in Ascent Pharmahealth, its subsidiary with operations in Australia and Southeast Asia, to NYSE-listed Watson Pharmaceuticals for AU$ 375 million (Rs

Drug firm Strides Arcolab today said it has sold its entire stake in its Australian subsidiary Ascent Pharmahealth to Watson Pharmaceuticals for AUD 375 million (over Rs 1,970 crore).

"As

Indian drugmaker Strides Arcolab is considering the sale of its Australian branded-generics unit, Ascent Pharmahealth, a national daily reported on Monday.

US investment bank Jefferies and Co is advising Strides

Drug firm Strides Arcolab today said it has received the US health regulator's nod to market Acarbose tablets, an anti-diabetic drug, in the American market.

The company has received approval